George L. Bakris

George L. Bakris (June 15, 1952June 15, 2024) was a Greek American physician and professor of medicine, specialising in kidney disease and hypertension.

He published more than 1100 journal articles and had an ''h''-index of 135. He worked on research into both therapies and drugs for the control of hypertension, and contributed to new guidelines for its treatment in the United States. Provided by Wikipedia
Showing 1 - 17 results of 17 for search 'George L. Bakris', query time: 0.05s Refine Results
  1. 1
    The evolution of “pillars of therapy” to reduce heart failure risk and slow diabetic kidney disease progression

    The evolution of “pillars of therapy” to reduce heart failure risk and slow diabetic kidney disease progression by Olivia Blazek, George L. Bakris

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Slowing the Progression of Diabetic Kidney Disease

    Slowing the Progression of Diabetic Kidney Disease by Olivia Blazek, George L. Bakris

    Published 2023-07-01
    Get full text
    Article
  3. 3
    Taking a step back: Making sense of evidence on diastolic blood pressure in the context of targets for older adults

    Taking a step back: Making sense of evidence on diastolic blood pressure in the context of targets for older adults by Vincent D. Salvador, George L. Bakris

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Initial Single‐Pill Blood Pressure–Lowering Therapy: Should It Be for Most People?

    Initial Single‐Pill Blood Pressure–Lowering Therapy: Should It Be for Most People? by Omar Al Dhabyi, George L. Bakris

    Published 2017-11-01
    Get full text
    Article
  5. 5
    Renin inhibition in patients with chronic kidney disease: Is it conclusively non-indicated?

    Renin inhibition in patients with chronic kidney disease: Is it conclusively non-indicated? by Pantelis A Sarafidis, George L Bakris

    Published 2014-03-01
    Get full text
    Article
  6. 6
    Newer alternatives for resistant hypertension: Beyond 2022 paradigms

    Newer alternatives for resistant hypertension: Beyond 2022 paradigms by Luke J. Laffin, Alexandros Briasoulis, George L. Bakris

    Published 2023-03-01
    Get full text
    Article
  7. 7
    Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems

    Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems by Peter Kolkhof, Robert Lawatscheck, Gerasimos Filippatos, George L. Bakris

    Published 2022-08-01
    Get full text
    Article
  8. 8
    Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection

    Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection by Erin D. Michos, George L. Bakris, Helena W. Rodbard, Katherine R. Tuttle

    Published 2023-06-01
    Get full text
    Article
  9. 9
    Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone

    Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone by Nicholas Chiu, Rahul Aggarwal, George L. Bakris, Bertram Pitt, Deepak L. Bhatt

    Published 2022-04-01
    Get full text
    Article
  10. 10
    Early and Chronic Dipeptidyl‐Peptidase‐IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial

    Early and Chronic Dipeptidyl‐Peptidase‐IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of th... by Abhinav Sharma, Christopher P. Cannon, William B. White, Yuyin Liu, George L. Bakris, William C. Cushman, Faiez Zannad

    Published 2018-06-01
    Get full text
    Article
  11. 11
    Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial

    Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Tri... by Abhinav Sharma, Muthiah Vaduganathan, João Pedro Ferreira, Yuyin Liu, George L. Bakris, Christopher P. Cannon, William B. White, Faiez Zannad

    Published 2020-01-01
    Get full text
    Article
  12. 12
    FINERENONE IN CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES: A FIDELITY ANALYSIS OF LEFT VENTRICULAR HYPERTROPHY

    FINERENONE IN CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES: A FIDELITY ANALYSIS OF LEFT VENTRICULAR HYPERTROPHY by Luis Matavelli, Gerasimos Filippatos, Stefan D. Anker, George L. Bakris, Peter Rossing, Luis M. Ruilope, Luke Roberts, Meike Brinker, Alfredo Farjat, Bertram Pitt

    Published 2023-09-01
    Get full text
    Article
  13. 13
    Average Clinician‐Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial

    Average Clinician‐Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial by William B. White, Fatima Jalil, William C. Cushman, George L. Bakris, Richard Bergenstal, Simon R. Heller, Yuyin Liu, Cyrus Mehta, Faiez Zannad, Christopher P. Cannon

    Published 2018-10-01
    Get full text
    Article
  14. 14
    Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials

    Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials by George L Bakris, Peter Rossing, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Shweta Bansal, Maria E F Canziani, Rita Birne, Luis M Ruilope, Alfredo E Farjat, Peter Kolkhof, Andrea Lage, Meike Brinker

    Published 2024-03-01
    Get full text
    Article
  15. 15
    Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

    Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials by John M. Flack, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luis M. Ruilope, Peter Rossing, Sharon G. Adler, Linda Fried, Kenneth Jamerson, Robert Toto, Meike Brinker, Alfredo E. Farjat, Peter Kolkhof, Robert Lawatscheck, Amer Joseph, George L. Bakris

    Published 2023-12-01
    Get full text
    Article
  16. 16
    Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

    Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis by Sylvia E. Rosas, Luis M. Ruilope, Stefan D. Anker, Bertram Pitt, Peter Rossing, Andres Angelo Cadena Bonfanti, Ricardo Correa-Rotter, Fernando González, Carlos Francisco Jaramillo Munoz, Pablo Pergola, Guillermo E. Umpierrez, Andrea Scalise, Charlie Scott, Robert Lawatscheck, Amer Joseph, George L. Bakris

    Published 2023-10-01
    Get full text
    Article
  17. 17
    Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

    Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering by Bernard Zinman, Bruce Neal, George L Bakris, Vlado Perkovic, Meg J Jardine, Kris Rogers, Jie Yu, Adeera Levin, Dick de Zeeuw, Hong Zhang, Kenneth W Mahaffey, Clare Arnott, Rajiv Agarwal, Gian Luca Di Tanna, Carol Pollock, David C Wheeler, Christopher P Cannon, David M Charytan, Hiddo J Lambers Heerspink, Norman Rosenthal

    Published 2023-05-01
    Get full text
    Article

Search Tools: